HCV - HGS to spin off gene research
HGS to spin off gene research
Baltimore Sun, United States - Dec 14, 2005... but has several in Phase 1 and Phase 2 clinical trials, including treatments for anthrax, HIV/AIDS, lupus, rheumatoid arthritis, chronic hepatitis C and forms ...
Texas Scientists Discover How A Hepatitis C Protein Promotes Liver ...
Science Daily (press release) - Dec 6, 2005... Approximately 200 million people worldwide suffer from chronic hepatitis C, which can persist in the body for decades after an initial infection, often causing ...
MIGENIX Completes License Agreement for MX-594AN - Establishes ...
PR Newswire (press release), NY - Dec 8, 2005... The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II), the prevention of catheter-related ...
Three Rivers Pharmaceuticals Announces FDA Final Approval of ...
PharmaLive.com (press release), PA - Dec 5, 2005CRANBERRY TOWNSHIP, Pa., December 05, 2005 /PRNewswire/ -- Three Rivers Pharmaceuticals, LLC today announced that the US Food and Drug Administration (FDA) has ...

<< Home